QCOM
57
-9
HES
42
2
UHS
64
-2
AMT
38
2
RL
80
-3
AMG
68
-7
AMGN
23
-3
C
72
-2
KLAC
63
-2
LNC
60
7
SE
80
-8
MSI
44
-3
WDC
61
-2
PNC
65
-2
SRE
57
-2
NVDA
61
-2
LLY
56
9
FRT
50
-6
EQT
59
2
EA
60
-3
QCOM
57
-9
HES
42
2
UHS
64
-2
AMT
38
2
RL
80
-3
AMG
68
-7
AMGN
23
-3
C
72
-2
KLAC
63
-2
LNC
60
7
SE
80
-8
MSI
44
-3
WDC
61
-2
PNC
65
-2
SRE
57
-2
NVDA
61
-2
LLY
56
9
FRT
50
-6
EQT
59
2
EA
60
-3
Financhill
Back

Traws Pharma Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
19

TRAW
Traws Pharma

Last Price:
$1.33
Seasonality Move:
8.68%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRAW is experiencing slight selling pressure.

Traws Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.43 Sell
20-day SMA: 1.63 Sell
50-day SMA: 2.15 Sell
200-day SMA: 5.68 Sell
8-day EMA: 1.43 Sell
20-day EMA: 1.63 Sell
50-day EMA: 2.46 Sell
200-day EMA: 6.23 Sell

Traws Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 28.57 Sell
Chaikin Money Flow: -6623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.42 - 1.92) Sell
Bollinger Bands (100): (1.68 - 7.46) Sell

Traws Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Traws Pharma Stock

Is Traws Pharma Stock a Buy?

  • Traws Pharma share price is 1.33 while TRAW 8-day simple moving average is 1.43, which is a Sell signal.
  • The stock price of TRAW is 1.33 while Traws Pharma 20-day SMA is 1.63, which makes it a Sell.
  • Traws Pharma 50-day simple moving average is 2.15 while TRAW share price is 1.33, making it a Sell technically.
  • TRAW stock price is 1.33 and Traws Pharma 200-day simple moving average is 5.68, creating a Sell signal.

TRAW Technical Analysis vs Fundamental Analysis

Sell
19
Traws Pharma (TRAW) is a Sell

Is Traws Pharma a Buy or a Sell?

  • Traws Pharma stock is rated a Sell
    The current Traws Pharma [TRAW] share price is $1.33. The Score for TRAW is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.

Traws Pharma Stock Info

Market Cap:
6.7M
Price in USD:
1.33
Share Volume:
99.3K

Traws Pharma 52-Week Range

52-Week High:
19.44
52-Week Low:
1.26
Sell
19
Traws Pharma (TRAW) is a Sell

Traws Pharma Share Price Forecast

  • What is the Traws Pharma stock price today?
    The Traws Pharma stock price is 1.33 USD today.
  • Will TRAW stock go up or go down?
    Traws Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Traws Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Traws Pharma is overvalued.

Is Traws Pharma Stock a Buy?

  • Traws Pharma share price is 1.33 while TRAW 8-day exponential moving average is 1.43, which is a Sell signal.
  • The stock price of TRAW is 1.33 while Traws Pharma 20-day EMA is 1.63, which makes it a Sell.
  • Traws Pharma 50-day exponential moving average is 2.46 while TRAW share price is 1.33, making it a Sell technically.
  • TRAW stock price is 1.33 and Traws Pharma 200-day simple moving average is 6.23, creating a Sell signal.

Technical Analysis of Traws Pharma

Should I short Traws Pharma stock?

* Traws Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.